Metafoodx | $9,400,000 | (May 16, 2025)
Ascendx | $110,000,000 | (May 16, 2025)
Algoma | $2,300,000 | (May 16, 2025)
Certified by Founder
Lodge
DISCO Pharmaceuticals GmbH
start up
Germany
- Cologne, North Rhine-Westphalia
- 17/01/2024
- Seed
- $21,727,000
DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients.
- Industry Pharmaceutical Manufacturing
- Website https://discopharma.de/
- LinkedIn https://www.linkedin.com/company/disco-pharmaceuticals-gmbh/about/
Plakar | $3,000,000 | (May 16, 2025)
Solestial, Inc. | $17,000,000 | (May 16, 2025)
Adyton PBC | $11,000,000 | (May 16, 2025)
Sproutr | Undisclosed Amount | (May 16, 2025)
Voltra | $1,800,000 | (May 16, 2025)
IMPRINT(US) | $15,000,000 | (May 16, 2025)
Sprinter Health | $55,000,000 | (May 16, 2025)
CarbonSix | $4,000,000 | (May 16, 2025)
Zeno Power | $50,000,000 | (May 16, 2025)